# Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance), Division 1: THE BLOOD COMPONENTS

Extent: E+W+S+N.I.

1.
Red cell preparations
The components listed in points 1.1 to 1.8 may be further processed within blood establishments and must be labelled accordingly
1.1
Red cells
1.2
Red cells, buffy coat removed
1.3
Red cells, leucocyte-depleted
1.4
Red cells, in additive solution
1.5
Red cells, buffy coat removed, in additive solution
1.6
Red cells, leucocyte-depleted, in additive solution
1.7
Red cells, apheresis
1.8
Whole blood
2.
Platelet preparations
The components listed in points 2.1 to 2.6 may be further processed within blood establishments and must be labelled accordingly
2.1
Platelets, apheresis
2.2
Platelets, apheresis, leucocyte-depleted
2.3
Platelets, recovered, pooled
2.4
Platelets, recovered, pooled, leucocyte-depleted
2.5
Platelets, recovered, single unit
2.6
Platelets, recovered, single unit, leucocyte-depleted
3.
Plasma preparations
The components listed in 3.1 to 3.3 may be further processed within blood establishments and must be labelled accordingly.
3.1
Fresh-frozen plasma
3.2
Fresh-frozen plasma, cryoprecipitate-depleted
3.3
Cryoprecipitate
4.
Granulocytes, apheresis
5.
New components
Quality and safety requirements for new blood components must be regulated by the competent national authority. Such new components must be notified to the European Commission with a view to Community action

---
Source: https://www.legislation.gov.uk/eudr/2004/33/annex/V/division/1 (the official version)
Page: https://openlegislation.uk/eu-directive-2004-33/annex-V/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.